Breast Biopsy Devices Market Snapshot (2022 to 2032)

Global demand for the breast biopsy devices market is set to display growth at a CAGR of about 5.5% from 2022 to 2032, with an estimated market valuation to be around US$ 2.1 Billion as of 2022. As per Future Market Insights projections, the biopsy needle segment as a product holds a substantial share of about 23.4% of the global market in 2021.

Market Outlook:

Data Points Market Insights
Market Value 2021 US$ 2.0 Billion
Market Value 2022 US$ 2.1 Billion
Market Value 2032 US$ 3.6 Billion
CAGR 2022 to 2032 5.5%
Market Share of Top 5 Countries 54.7%
Key Market Players Argon Medical Devices, Becton Dickinson and Company., C.R. Bard, Inc. Cook Medical Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic, Inc. Leica Biosystems, Max Srl Unipersonale, Planmed Oy, Scion Medical Technologies, LLC, and Siemens Healthier.

Changes in one's way of life, such as behavior, nutritional preferences, and physical activity, might make breast cancer worse. Women who are overweight have higher blood insulin levels. Several cancers, particularly breast cancer, have been linked to elevated insulin levels.

Alcohol use, being overweight, using birth control, taking menopausal hormone therapy, and having breast implants are all lifestyle choices that can result in breast cancer. An increase in life expectancy is the reason that is anticipated to promote the expansion of the breast biopsy devices market.

Furthermore, a sophisticated biopsy strategy may enable radiologists and surgeons to perform breast procedures with greater accuracy, simplicity, and convenience. Large chances are being created for players to enter this industry and take over market space with new technology.

It will thus help the market to further grow, by improving the product offering in the market by the key players during the forecast period from 2022 to 2032.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Breast Biopsy Devices Market from 2012 to 2021 vs. Market Outlook for 2022 to 2032

The global market for breast biopsy devices expanded at a CAGR of 3.6% over the span of 2012 to 2021.

The market value for breast biopsy devices market holds approximately 50% of the overall US$ 4 Billion global breast cancer diagnostics market in 2021

The growing prevalence of breast cancer will drive the demand for breast biopsy devices shortly. The global burden of breast cancer is increasing owing to the growing population along with the changing lifestyle and excessive consumption of tobacco and alcohol. Breast cancer is a major public health issue in low- and middle-income countries. Besides, factors that also contribute to the existing disease burden are poor quality control, low mammography coverage, insufficient physical and human resources for clinical care, and limited access to diagnosis and treatment

The breast cancer-related mortality rate is high among women worldwide. Breast cancer is a major concern throughout the globe. Increased parity, premenopausal status, and shorter duration of breastfeeding are certainly associated with an increased risk of triple-negative breast cancer.

The risk of breast cancer is directly proportional to age. Considering the large geriatric female population, along with increasing awareness about breast cancer and the importance of early detection of the disease, demand for breast surgery retractors is expected to grow rapidly.

In order to study the asymptomatic population, which has an average cancer risk, particularly for breast cancer, appropriate screening techniques must be used. It is crucial that medical professionals, other healthcare workers, and the general public have a better grasp of the early warning signs and symptoms of cancer. The market will grow faster if healthcare policies in developing nations are improved.

Minimally invasive surgeries are gaining a lot of attention because they are not only clinically safer for the patients but also very cost-effective. They also help enable faster recovery.

These surgeries are less painful and since they involve endoscopic and robotic assistance, the precision of the results increases as well, which has a positive impact on the patient’s quality of life.

The rise in the acceptance of liquid biopsies for achieving early detection of cancer reflects the movement towards less invasive procedures.

Additionally, market participants for breast biopsy devices are concentrating on collaborating with hospitals and ambulatory surgical centers for direct sales and maintenance of the equipment as well as training staff to raise knowledge of cutting-edge technology.

An increase in the funding for cancer research has driven many cancer research institutes and has led to substantial improvements in patient survival rates and dramatic improvements in the quality of life for patients with cancer.

The market is expected to expand at a significant rate over the next ten years at a CAGR close to 5.5% and offers an absolute $ opportunity of US$ 109.3 Million.

The above-mentioned factors are primarily insightful concerning the global sales growth of the breast biopsy devices market and are anticipated to persistently progress market growth over the forecasted period of 2022 to 2032.

Breast Biopsy Devices Market

What are the Key Opportunities for Breast Biopsy Device Manufacturers?

Breast Biopsy Devices are becoming more used in the detection and mapping of breast cancer. However, only a few players that are actively engaged in the manufacturing of breast biopsy devices to date, implying that there are significant opportunities for other small and large manufacturers to enter the market, as demand for the devices is rapidly increasing.

Breast cancer is the most common cancer in emerging nations, and it is growing rapidly among women in metropolitan regions. The importance of early detection in the management and treatment of this condition cannot be overstated. As a result, breast cancer awareness activities are organized to raise awareness and eliminate the stigma associated with breast cancer symptoms and treatment.

This increasing incidence rate creates huge opportunities for market players in emerging regions.

A greater patient base with cancer and rising per capita income would also create profitable chances for market penetration and economic expansion across the globe.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Demand for Breast Biopsy Devices?

The expensive expense of devices, as well as a scarcity of qualified specialists capable of carrying out important and advanced cancer detection processes, are constraints limiting demand for breast biopsy devices. Breast cancer surgeries, such as breast lumpectomy, biopsy, and other procedures, are expensive. The high cost of the equipment, the expense of associated high services, and equipment that are inaccessible to most patients in most countries are major market restraints.

Breast Biopsy Devices are the most advanced method for the detection and removal of cysts. This method requires expertise on the part of the staff and trainees. Many hospitals and healthcare centers lack such skilled professionals to use these devices during diagnosis or surgeries.

Thus, the lack of trained staff and other challenges are expected to hamper the adoption of these devices, which in turn is expected to restrain the market’s growth.

What Makes the USA the Largest Market for Breast Biopsy Devices?

The USA led the North American region with a market share of about 88.6% in the year 2021 and is estimated to show higher growth in this sector, in comparison to Canada, throughout the forecast period. The American Cancer Society's estimate for breast cancer in the USA for 2022 is about 287,850 new cases of invasive breast cancer, which is projected to surge the demand for core needle biopsy devices.

The rise in the prevalence of breast cancer, raising awareness of breast cancer early detection, improving government expenditures on breast cancer research, and increasing usage of devices in cancer centers is the primary factor boosting the USA breast biopsy devices market growth in the region. Because of the total replacement of conventional open surgical biopsy techniques with less invasive alternatives, the USA has turned out to be the largest geographical market for breast biopsy devices.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Why is the United Kingdom. Considered a Lucrative Market for Breast Biopsy Devices in Europe?

United Kingdom is set to exhibit a CAGR of nearly 5.6% in the European breast biopsy devices market during the forecast period. Since the population in the United Kingdom is more conscious of their own health, and cancer screening and diagnosis rates are both high in this country, the market for breast biopsy equipment is expected to expand at a quicker rate there. In addition, the huge population and adult population of the United Kingdom is more susceptible to getting breast cancer as a result of weakened immune systems and changing lifestyles.

Other than that, the market for breast biopsy devices is also getting driven in developed economies such as France, Germany, and Spain by these same factors, consequently surging the sales of breast biopsy devices in Europe. The region's fast-rising countries have invested in infrastructure development for research in the healthcare sector, propelling the breast biopsy devices market growth.

What Makes Japan an Emerging Market for Breast Biopsy devices?

During the projected period, the North American industry is expected to lose considerable market share to the fast-expanding Asia-Pacific market. China is the fastest growing, with a CAGR of 6.4% in the East Asia market during the forecast period. However, in recent years Japan has also emerged to be a growing market for vacuum biopsy needles which is inferred to be a challenge to China’s dominance in the region.

The increased number of breast cancer patients in the country mirrors the country's growing dominance in the biopsy devices market in the Asia Pacific region. Furthermore, the emergence of Japan's breast biopsy devices market is linked to increased reimbursements for the most recent and sophisticated biopsy techniques by the national and regional governments.

How has South Korea entered the Global Competition in Breast Biopsy Devices Manufacturing?

The South Korean breast biopsy devices market is being driven by the rapid development of healthcare infrastructure, the increasing replacement of stereotactic X-ray biopsy systems with MRI-guided systems, and the growing number of breast cancer patients. Furthermore, the rapid growth of medical tourism in the region would provide breast biopsy device manufacturers with further market recognition potential.

Breast cancer's growing incidence rate has created critical commercial growth prospects for South Korean breast biopsy device market players. Furthermore, technical developments and breakthroughs in breast biopsy instruments are driving this market to expand in Asia Pacific countries, including South Korea. Unfortunately, the many negative side effects of the procedure, as well as the expensive price, may still restrict the regional market from expanding to its full potential.

Country-wise Insights

What Makes the USA the Largest Market for Breast Biopsy Devices?

The USA leads the North American region with a market share of about 88.6% in 2021 and is estimated to show high growth throughout the forecast period. The rise in the prevalence of breast cancer, raising awareness of breast cancer early detection, improving government expenditures on breast cancer research, and increasing usage of devices in cancer centers in the USA is the major factor boosting the market growth in the region.

The American Cancer Society's estimate for breast cancer in the USA for 2022 is about 287,850 new cases of invasive breast cancer will be diagnosed in women

Why is the United Kingdom Considered a Lucrative Market for Breast Biopsy Devices in Europe?

United Kingdom is set to exhibit a CAGR of nearly 5.6% in the European breast biopsy devices market during the forecast period. Since the population in the United Kingdom is more conscious of their own health and cancer screening and diagnosis rates are both high in this country, the market for breast biopsy equipment is expected to expand at a quicker rate there.

In addition, the huge population and adult population of the United Kingdom is more susceptible to getting breast cancer as a result of weakened immune systems and changing lifestyles. The market for breast biopsy devices is driven by these factors.

What Makes China an Emerging Market for Breast Biopsy devices?

China is the fastest growing with a CAGR of 6.4% in the East Asia market during the forecast period. The increased number of breast cancer patients in the country mirrors the country's dominance in the breast biopsy devices market.

Nearly 416 thousand new instances of breast cancer were estimated to have been discovered in Chinese women in 2020, according to statistics.

Category-wise Insights

Which Breast Biopsy Device Product is Driving Market Growth?

Biopsy needles segment projects lucrative growth holding a market share of around 23.4% in 2021, owing to its cost-effectiveness, and ease for surgeons and radiologists to use it while surgeries. To identify the origin of an abnormality, a thin, hollowed needle, and syringe are used to collect cells, fluids, or tissues from a suspected mass or another abnormal part of the body. These samples are then inspected under a microscope or evaluated in a lab. A needle biopsy can determine whether a lump or mass is a benign tumor, cyst, infection, or malignancy. The market for breast biopsy devices is being driven by these various considerations.

Which Indication is driving the Breast Biopsy Devices Market Growth?

Complex cyst estimates a lucrative growth opportunity at a CAGR of 6.1% throughout the forecast period of 2022 to 2032 and shows a market share of around 37.2% in 2021. Complex breast cysts are defined as cysts with thick walls, thick septa, intracystic masses, or other discrete solid components. Breast cysts are extremely common and are present in most women over 40 years old. Breast ultrasound allows its detection and the correct diagnosis of cysts has been reported to be almost 100%. This makes the biopsy segment grow with great market space.

Which End User Benefits the Most by Employment of Breast Biopsy Devices?

Hospitals as end users lead the breast biopsy devices market with about 34.2% market share in 2021. Hospitals have a huge amount of footfall for diagnosis and surgeries of breast cancer also companies are focusing on unique strategies of training surgeons and radiologists in hospitals for more patient reach this is gaining traction.

Competitive Landscape

Key players are focused on the development and launch of novel detection devices for breast cancers. Established players within the industry are targeting specific female groups and going after strategic mergers and acquisitions to strengthen their position in the breast biopsy devices market.

  • For instance, in Mar 2022, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, opened its Innovation Center today in Aix-en-Provence, France. The new commercial office and training and research and development facility will support Hologic’s ultrasound, interventional, and surgical solutions across the continuum of breast health care.
  • In April 2021, Unilabs and GE Healthcare signed a partnership agreement. GE Healthcare provides technically advanced MRIs and CT scanning technology, ultrasound devices, mammography, and X-ray machines to Unilabs in Portugal.

Similarly, recent developments related to companies manufacturing breast biopsy device techniques have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Breast Biopsy Devices Industry Analysis

Attribute Details
Forecast Period 2022 to 2032
Historical Data Available for 2012 to 2021
Market Analysis US$ Million for Value and Volume in Units
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, BENELUX, Nordic countries, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey, and South Africa
Key Market Segments Covered Product, Indication, End User, and Region
Key Companies Profiled
  • ARGON MEDICAL
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy,
  • Scion Medical Technologies, LLC
  • Siemens Healthier
Pricing Available upon Request

Key Market Segments Covered in Breast biopsy Devices Industry Research

By Product:

  • Biopsy Needle
    • Core Needles
    • Fine Aspiration Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
    • Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
    • Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
  • Vacuum-Assisted Device (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Marker

By Indication:

  • Complex cyst
  • Solid mass
  • Suspicious solid mass( fibroadenoma )
  • Suspicious micro-calcifications

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

How much is the breast biopsy devices market currently worth?

The global breast biopsy devices market is worth US$ 2.0 Billion in 2021 and is set to expand by 1.7X over the next ten years.

What is the sales forecast for breast biopsy devices through 2032?

The breast biopsy devices market is expected to reach US$ 3.6 Billion by the end of 2032, with sales revenue expected to register at 5.5% CAGR.

What are the factors driving the demand outlook for global breast biopsy devices?

Increasing incidence of breast cancer, growing life expectancy rate, and an increase in the funding for cancer research are some of the key factors driving the demand in the marketplace.

Which is the most lucrative market for breast biopsy devices?

North America holds 32.0% of the global breast biopsy devices market in 2021 with the USA being the leading contributor in the North American region with a market value of about US$ 568.9 Million in 2021.

How likely is the breast biopsy devices market to grow in India?

The breast biopsy devices market in India is likely to grow at a CAGR of 7.4% during the forecast period, with a market share of around 45.6% in 2021 in the South Asian market for breast biopsy devices.

What are the key trends driving sales of breast biopsy devices?

Acquisitions and collaborations by key players, emerging technologies to enhance the market reach, and a shift from invasive to minimally-invasive surgical procedures are some of the key trends being witnessed in this marketplace.

What are the key market statistics in Japan?

Japan’s market in breast biopsy devices is offering lucrative growth opportunities and is expected to exhibit healthy growth of 5.8% CAGR during the forecast period.

What are the top 5 countries driving demand for breast biopsy devices?

The U.S., Japan, the United Kingdom, Germany, and China are expected to drive demand for breast biopsy devices.

What was the last 09 year’s market CAGR for breast biopsy devices?

From 2012 to 2021, the market for breast biopsy devices expanded at a CAGR of 3.6%.

Which are the leading companies in the breast biopsy devices market?

Argon Medical Devices, Becton Dickinson and Company. C.R. Bard, Inc. Cook Medical Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Hologic, Inc. Leica Biosystems, Medax Srl Unipersonale, Planmed Oy, Scion Medical Technologies, LLC, and Siemens Healthineer, are the key exporter of the breast biopsy devices market.

Table of Content
1. Executive Summary | Breast Biopsy Devices Market
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusion and Exclusion
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Product Innovation / Development Trends
4. Key Success Factors
    4.1. Product Adoption / Usage Analysis
    4.2. Key Promotional Strategies, by Manufacturers
    4.3. Regulatory Scenario
    4.4. PESTLE Analysis
    4.5. Porter’s Analysis
    4.6. New Product Launches
    4.7. Technology Assessment
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Expenditure Market Outlook
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Rising demand for Breast Biopsy Devices
        5.2.2. Cost of Procedures
        5.2.3. Adoption Rate
        5.2.4. Increase in Research and Development
        5.2.5. Availability
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
    6.1. COVID-19 and Impact Analysis
        6.1.1. Revenue By Product
        6.1.2. Revenue By Indication
        6.1.3. Revenue By End User
        6.1.4. Revenue By Country
    6.2. 2021 Market Scenario
7. Global Market Demand (in Volume Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032
    7.1. Historical Market Volume (Units) Analysis, 2012 to 2021
    7.2. Current and Future Market Volume (units) Projections, 2022 to 2032
        7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market- Pricing Analysis
    8.1. Regional Pricing Analysis by Product
    8.2. Pricing Break-up
        8.2.1. Manufacturer-Level Pricing
        8.2.2. Distributor Level Pricing
    8.3. Global Average Pricing Analysis Benchmark
    8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
    9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
    9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
        9.2.1. Y-o-Y Growth Trend Analysis
        9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Million) Analysis & Volume (Units) by Product, 2012 to 2021
    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2032
        10.3.1. Biopsy Needle
            10.3.1.1. Core Needles
            10.3.1.2. Fine Aspiration Needles
        10.3.2. MRI-Guide Biopsy Systems
        10.3.3. Ultrasound Guided Breast Biopsy Systems
            10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
            10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
        10.3.4. Vacuum-Assisted Device (VAD)
        10.3.5. Guide Wire (Localization Wire)
        10.3.6. Breast Biopsy Marker
    10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Indication
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Million) Analysis by Indication, 2012 to 2021
    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2022 to 2032
        11.3.1. Complex Cyst
        11.3.2. Solid Mass
        11.3.3. Suspicious Solid Mass
        11.3.4. Suspicious Micro Calcifications
        11.3.5. Suspicious Architectural Distortion
    11.4. Market Attractiveness Analysis by Indication
12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
    12.1. Introduction / Key Findings
    12.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2021
    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
        12.3.1. Hospitals
        12.3.2. Specialty Clinics
        12.3.3. Ambulatory Surgical Centers
        12.3.4. Cancer Research Institutes
    12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region
    13.1. Introduction
    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2012 to 2021
    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2022 to 2032
        13.3.1. North America
        13.3.2. Latin America
        13.3.3. Europe
        13.3.4. South Asia
        13.3.5. East Asia
        13.3.6. Oceania
        13.3.7. Middle East & Africa(MEA)
    13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    14.1. Introduction
    14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2021
    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2022 to 2032
        14.3.1. By Country
            14.3.1.1. USA
            14.3.1.2. Canada
        14.3.2. By Product
        14.3.3. By Indication
        14.3.4. By End User
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Product
        14.4.3. By Indication
        14.4.4. By End User
    14.5. Country-Level Analysis & Forecast
        14.5.1. USA Market
            14.5.1.1. Introduction
            14.5.1.2. Market Analysis and Forecast by Market Taxonomy
                14.5.1.2.1. By Product
                14.5.1.2.2. By Indication
                14.5.1.2.3. By End User
        14.5.2. Canada Market
            14.5.2.1. Introduction
            14.5.2.2. Market Analysis and Forecast by Market Taxonomy
                14.5.2.2.1. By Product
                14.5.2.2.2. By Indication
                14.5.2.2.3. By End-User
15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    15.1. Introduction
    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2021
    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2022 to 2032
        15.3.1. By Country
            15.3.1.1. Brazil
            15.3.1.2. Mexico
            15.3.1.3. Argentina
            15.3.1.4. Rest of Latin America
        15.3.2. By Product
        15.3.3. By Indication
        15.3.4. By End User
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Product
        15.4.3. By Indication
        15.4.4. By End User
    15.5. Country-Level Analysis & Forecast
        15.5.1. Brazil Market
            15.5.1.1. Introduction
            15.5.1.2. Market Analysis and Forecast by Market Taxonomy
                15.5.1.2.1. By Product
                15.5.1.2.2. By Indication
                15.5.1.2.3. By End User
        15.5.2. Mexico Market
            15.5.2.1. Introduction
            15.5.2.2. Market Analysis and Forecast by Market Taxonomy
                15.5.2.2.1. By Product
                15.5.2.2.2. By Indication
                15.5.2.2.3. By End User
        15.5.3. Argentina Market
            15.5.3.1. Introduction
            15.5.3.2. Market Analysis and Forecast by Market Taxonomy
                15.5.3.2.1. By Product
                15.5.3.2.2. By Indication
                15.5.3.2.3. By End User
16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    16.1. Introduction
    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021
    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        16.3.1. By Country
            16.3.1.1. Germany
            16.3.1.2. Italy
            16.3.1.3. France
            16.3.1.4. United Kingdom
            16.3.1.5. Spain
            16.3.1.6. BENELUX
            16.3.1.7. Nordic Countries
            16.3.1.8. Russia
            16.3.1.9. Rest of Europe
        16.3.2. By Product
        16.3.3. By Indication
        16.3.4. By End User
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Product
        16.4.3. By Indication
        16.4.4. By End User
    16.5. Country-Level Analysis & Forecast
        16.5.1. Germany Market
            16.5.1.1. Introduction
            16.5.1.2. Market Analysis and Forecast by Market Taxonomy
                16.5.1.2.1. By Product
                16.5.1.2.2. By Indication
                16.5.1.2.3. By End User
        16.5.2. Italy Market
            16.5.2.1. Introduction
            16.5.2.2. Market Analysis and Forecast by Market Taxonomy
                16.5.2.2.1. By Product
                16.5.2.2.2. By Indication
                16.5.2.2.3. By End User
        16.5.3. France Market
            16.5.3.1. Introduction
            16.5.3.2. Market Analysis and Forecast by Market Taxonomy
                16.5.3.2.1. By Product
                16.5.3.2.2. By Indication
                16.5.3.2.3. By End User
        16.5.4. United Kingdom Market
            16.5.4.1. Introduction
            16.5.4.2. Market Analysis and Forecast by Market Taxonomy
                16.5.4.2.1. By Product
                16.5.4.2.2. By Indication
                16.5.4.2.3. By End User
        16.5.5. Spain Market
            16.5.5.1. Introduction
            16.5.5.2. Market Analysis and Forecast by Market Taxonomy
                16.5.5.2.1. By Product
                16.5.5.2.2. By Indication
                16.5.5.2.3. By End User
        16.5.6. BENELUX Market
            16.5.6.1. Introduction
            16.5.6.2. Market Analysis and Forecast by Market Taxonomy
                16.5.6.2.1. By Product
                16.5.6.2.2. By Indication
                16.5.6.2.3. By End User
        16.5.7. Nordic Countries Market
            16.5.7.1. Introduction
            16.5.7.2. Market Analysis and Forecast by Market Taxonomy
                16.5.7.2.1. By Product
                16.5.7.2.2. By Indication
                16.5.7.2.3. By End User
        16.5.8. Russia Market
            16.5.8.1. Introduction
            16.5.8.2. Market Analysis and Forecast by Market Taxonomy
                16.5.8.2.1. By Product
                16.5.8.2.2. By Indication
                16.5.8.2.3. By End User
17. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    17.1. Introduction
    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021
    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        17.3.1. By Country
            17.3.1.1. India
            17.3.1.2. Thailand
            17.3.1.3. Indonesia
            17.3.1.4. Malaysia
            17.3.1.5. Rest of South Asia
        17.3.2. By Product
        17.3.3. By Indication
        17.3.4. By End User
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Product
        17.4.3. By Indication
        17.4.4. By End User
    17.5. Country-Level Analysis & Forecast
        17.5.1. India Market
            17.5.1.1. Introduction
            17.5.1.2. Market Analysis and Forecast by Market Taxonomy
                17.5.1.2.1. By Product
                17.5.1.2.2. By Indication
                17.5.1.2.3. By End User
        17.5.2. Thailand Market
            17.5.2.1. Introduction
            17.5.2.2. Market Analysis and Forecast by Market Taxonomy
                17.5.2.2.1. By Product
                17.5.2.2.2. By Indication
                17.5.2.2.3. By End User
        17.5.3. Indonesia Market
            17.5.3.1. Introduction
            17.5.3.2. Market Analysis and Forecast by Market Taxonomy
                17.5.3.2.1. By Product
                17.5.3.2.2. By Indication
                17.5.3.2.3. By End User
        17.5.4. Malaysia Market
            17.5.4.1. Introduction
            17.5.4.2. Market Analysis and Forecast by Market Taxonomy
                17.5.4.2.1. By Product
                17.5.4.2.2. By Indication
                17.5.4.2.3. By End User
18. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    18.1. Introduction
    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021
    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        18.3.1. By Country
            18.3.1.1. China
            18.3.1.2. Japan
            18.3.1.3. South Korea
        18.3.2. By Product
        18.3.3. By Indication
        18.3.4. By End User
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Product
        18.4.3. By Indication
        18.4.4. By End User
    18.5. Country-Level Analysis & Forecast
        18.5.1. China Market
            18.5.1.1. Introduction
            18.5.1.2. Market Analysis and Forecast by Market Taxonomy
                18.5.1.2.1. By Product
                18.5.1.2.2. By Indication
                18.5.1.2.3. By End User
        18.5.2. Japan Market
            18.5.2.1. Introduction
            18.5.2.2. Market Analysis and Forecast by Market Taxonomy
                18.5.2.2.1. By Product
                18.5.2.2.2. By Indication
                18.5.2.2.3. By End User
        18.5.3. South Korea Market
            18.5.3.1. Introduction
            18.5.3.2. Market Analysis and Forecast by Market Taxonomy
                18.5.3.2.1. By Product
                18.5.3.2.2. By Indication
                18.5.3.2.3. By End User
19. Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032
    19.1. Introduction
    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021
    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        19.3.1. By Country
            19.3.1.1. Australia
            19.3.1.2. New Zealand
        19.3.2. By Product
        19.3.3. By Indication
        19.3.4. By End User
    19.4. Market Attractiveness Analysis
        19.4.1. By Country
        19.4.2. By Product
        19.4.3. By Indication
        19.4.4. By End User
    19.5. Country-Level Analysis & Forecast
        19.5.1. Australia Market
            19.5.1.1. Introduction
            19.5.1.2. Market Analysis and Forecast by Market Taxonomy
                19.5.1.2.1. By Product
                19.5.1.2.2. By Indication
                19.5.1.2.3. By End User
        19.5.2. New Zealand Market
            19.5.2.1. Introduction
            19.5.2.2. Market Analysis and Forecast by Market Taxonomy
                19.5.2.2.1. By Product
                19.5.2.2.2. By Indication
                19.5.2.2.3. By End User
20. Middle East & Africa Market Analysis 2012 to 2021and Forecast 2022 to 2032
    20.1. Introduction
    20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2021
    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2032
        20.3.1. By Country
            20.3.1.1. GCC Countries
            20.3.1.2. Turkey
            20.3.1.3. South Africa
            20.3.1.4. Rest of Middle East and Africa(MEA)
        20.3.2. By Product
        20.3.3. By Indication
        20.3.4. By End User
    20.4. Market Attractiveness Analysis
        20.4.1. By Country
        20.4.2. By Product
        20.4.3. By Indication
        20.4.4. By End User
    20.5. Country-Level Analysis & Forecast
        20.5.1. GCC Countries Market
            20.5.1.1. Introduction
            20.5.1.2. Market Analysis and Forecast by Market Taxonomy
                20.5.1.2.1. By Product
                20.5.1.2.2. By Indication
                20.5.1.2.3. By End User
        20.5.2. Turkey Market
            20.5.2.1. Introduction
            20.5.2.2. Market Analysis and Forecast by Market Taxonomy
                20.5.2.2.1. By Product
                20.5.2.2.2. By Indication
                20.5.2.2.3. By End User
        20.5.3. South Africa Market
            20.5.3.1. Introduction
            20.5.3.2. Market Analysis and Forecast by Market Taxonomy
                20.5.3.2.1. By Product
                20.5.3.2.2. By Indication
                20.5.3.2.3. By End User
21. Competition Analysis
    21.1. Competition Dashboard
    21.2. Competition Deep Dive
        21.2.1. Argon Medical Devices
            21.2.1.1. Overview
            21.2.1.2. Product Portfolio
            21.2.1.3. Key Financial
            21.2.1.4. Sales Footprint
            21.2.1.5. SWOT Analysis
            21.2.1.6. Strategy Overview
                21.2.1.6.1. Marketing Strategies
                21.2.1.6.2. Product Strategies
                21.2.1.6.3. Channel Strategies
        21.2.2. Becton Dickinson and Company
            21.2.2.1. Overview
            21.2.2.2. Product Portfolio
            21.2.2.3. Key Financial
            21.2.2.4. Sales Footprint
            21.2.2.5. SWOT Analysis
            21.2.2.6. Strategy Overview
                21.2.2.6.1. Marketing Strategies
                21.2.2.6.2. Product Strategies
                21.2.2.6.3. Channel Strategies
        21.2.3. C. R. Bard, Inc.
            21.2.3.1. Overview
            21.2.3.2. Product Portfolio
            21.2.3.3. Key Financial
            21.2.3.4. Sales Footprint
            21.2.3.5. SWOT Analysis
            21.2.3.6. Strategy Overview
                21.2.3.6.1. Marketing Strategies
                21.2.3.6.2. Product Strategies
                21.2.3.6.3. Channel Strategies
        21.2.4. Cook Medical Inc.
            21.2.4.1. Overview
            21.2.4.2. Product Portfolio
            21.2.4.3. Key Financial
            21.2.4.4. Sales Footprint
            21.2.4.5. SWOT Analysis
            21.2.4.6. Strategy Overview
                21.2.4.6.1. Marketing Strategies
                21.2.4.6.2. Product Strategies
                21.2.4.6.3. Channel Strategies
        21.2.5. Devicor Medical Products, Inc.
            21.2.5.1. Overview
            21.2.5.2. Product Portfolio
            21.2.5.3. Key Financial
            21.2.5.4. Sales Footprint
            21.2.5.5. SWOT Analysis
            21.2.5.6. Strategy Overview
                21.2.5.6.1. Marketing Strategies
                21.2.5.6.2. Product Strategies
                21.2.5.6.3. Channel Strategies
        21.2.6. F. Hoffmann-La Roche Ltd.
            21.2.6.1. Overview
            21.2.6.2. Product Portfolio
            21.2.6.3. Key Financial
            21.2.6.4. Sales Footprint
            21.2.6.5. SWOT Analysis
            21.2.6.6. Strategy Overview
                21.2.6.6.1. Marketing Strategies
                21.2.6.6.2. Product Strategies
                21.2.6.6.3. Channel Strategies
        21.2.7. GE Healthcare
            21.2.7.1. Overview
            21.2.7.2. Product Portfolio
            21.2.7.3. Key Financial
            21.2.7.4. Sales Footprint
            21.2.7.5. SWOT Analysis
            21.2.7.6. Strategy Overview
                21.2.7.6.1. Marketing Strategies
                21.2.7.6.2. Product Strategies
                21.2.7.6.3. Channel Strategies
        21.2.8. Hologic, Inc.
            21.2.8.1. Overview
            21.2.8.2. Product Portfolio
            21.2.8.3. Key Financial
            21.2.8.4. Sales Footprint
            21.2.8.5. SWOT Analysis
            21.2.8.6. Strategy Overview
                21.2.8.6.1. Marketing Strategies
                21.2.8.6.2. Product Strategies
                21.2.8.6.3. Channel Strategies
        21.2.9. Leica Biosystems
            21.2.9.1. Overview
            21.2.9.2. Product Portfolio
            21.2.9.3. Key Financial
            21.2.9.4. Sales Footprint
            21.2.9.5. SWOT Analysis
            21.2.9.6. Strategy Overview
                21.2.9.6.1. Marketing Strategies
                21.2.9.6.2. Product Strategies
                21.2.9.6.3. Channel Strategies
        21.2.10. Medax Srl Unipersonale
            21.2.10.1. Overview
            21.2.10.2. Product Portfolio
            21.2.10.3. Key Financial
            21.2.10.4. Sales Footprint
            21.2.10.5. SWOT Analysis
            21.2.10.6. Strategy Overview
                21.2.10.6.1. Marketing Strategies
                21.2.10.6.2. Product Strategies
                21.2.10.6.3. Channel Strategies
        21.2.11. Planmed Oy
            21.2.11.1. Overview
            21.2.11.2. Product Portfolio
            21.2.11.3. Key Financial
            21.2.11.4. Sales Footprint
            21.2.11.5. SWOT Analysis
            21.2.11.6. Strategy Overview
                21.2.11.6.1. Marketing Strategies
                21.2.11.6.2. Product Strategies
                21.2.11.6.3. Channel Strategies
        21.2.12. Scion Medical Technologies, LLC
            21.2.12.1. Overview
            21.2.12.2. Product Portfolio
            21.2.12.3. Key Financial
            21.2.12.4. Sales Footprint
            21.2.12.5. SWOT Analysis
            21.2.12.6. Strategy Overview
                21.2.12.6.1. Marketing Strategies
                21.2.12.6.2. Product Strategies
                21.2.12.6.3. Channel Strategies
        21.2.13. Siemens Healthier
            21.2.13.1. Overview
            21.2.13.2. Product Portfolio
            21.2.13.3. Key Financial
            21.2.13.4. Sales Footprint
            21.2.13.5. SWOT Analysis
            21.2.13.6. Strategy Overview
                21.2.13.6.1. Marketing Strategies
                21.2.13.6.2. Product Strategies
                21.2.13.6.3. Channel Strategies
22. Assumptions and Acronyms Used
23. Research Methodology
Recommendations

Healthcare

Breast Pump Market

November 2023

REP-GB-5820

338 pages

Healthcare

Cancer Diagnostics Market

August 2023

REP-GB-1090

315 pages

Healthcare

Gamma Probe Devices Market

February 2023

REP-GB-10037

268 pages

Healthcare

Cancer Supportive Care Products Market

July 2020

REP-GB-2550

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Breast Biopsy Devices Market

Schedule a Call